Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LY6G6D |
| Upstream (Parents) |
|---|
| (<<) PLAGL2 → LY6G6D |
| (<<) CDX2 → LY6G6D |
| Downstream (Children) |
|---|
| LY6G6D → ARID3A (>>) |
| LY6G6D → DNAJC15 (>>) |
| LY6G6D → NEK3 (>>) |
| LY6G6D → NT5E (>>) |
| LY6G6D → ACSL6 (>>) |
| LY6G6D → SLC26A3 (>>) |
| LY6G6D → DACH1 (>>) |
| LY6G6D → HEYL (>>) |
| LY6G6D → MLPH (>>) |
| LY6G6D → LY6G6E (>>) |
| LY6G6D → PIGR (>>) |
| LY6G6D → SLC6A4 (>>) |
| LY6G6D → GPR143 (>>) |
| LY6G6D → SESN1 (>>) |
| LY6G6D → TLE2 (>>) |
| LY6G6D → SLC1A7 (>>) |
| LY6G6D → CAB39L (>>) |
